Sonic Hedgehog Signaling in Thyroid Cancer

Area of Science:

• Oncology
• Molecular Biology
• Endocrinology

Background:

• Thyroid cancer is the most common endocrine malignancy.
• Genetic mutations in PI3K/MAPK pathways (e.g., RAS, BRAF) or RET/PTC rearrangements initiate thyroid cancer.
• The sonic hedgehog (Shh) pathway is crucial for embryonic development and implicated in basal cell carcinoma.

Purpose of the Study:

• To review Shh pathway activation in thyroid cancer.
• To examine the role of Shh in thyroid cancer stem cell (CSC) self-renewal.
• To summarize Shh pathway crosstalk with MAPK and PI3K pathways for combination therapy.

Main Methods:

• Literature review of recent findings on Shh pathway in thyroid cancer.
• Analysis of Shh pathway's role in CSC self-renewal.
• Summary of crosstalk mechanisms between Shh, MAPK, and PI3K pathways.

Main Results:

• Shh pathway activation stimulates growth and spread in various cancers, including thyroid cancer.
• The Shh pathway is vital for maintaining thyroid CSC self-renewal.
• Crosstalk exists between Shh and oncogenic MAPK/PI3K pathways.

Conclusions:

• Shh pathway activation is a significant factor in thyroid cancer progression and CSC maintenance.
• Understanding Shh pathway interactions with MAPK and PI3K pathways is crucial for developing effective combination therapies.
• Shh inhibitors (e.g., GDC-0449, LDE-225) show potential for thyroid cancer treatment.